Jackson Simon
Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford, UK.
Curr Med Res Opin. 2005 Oct;21(10):1669-75. doi: 10.1185/030079905X65565.
Stress urinary incontinence is the most prevalent form of urinary incontinence. In spite of its significant negative impact on quality of life less than one-third of patients in the UK present with symptoms to their GP. The current mainstay treatment is pelvic floor exercises. Previously, the only option available to patients for whom conservative treatments were not effective has been surgical intervention. However, recent developments have led to the first selective serotonin and noradrenaline reuptake inhibitor that has proved effective in the treatment inhibitor of stress urinary incontinence. This article profiles current treatments and the place of an oral agent in stress urinary incontinence. This review article includes papers that were retrieved through PubMed using search criteria 'stress urinary incontinence', 'management' and the specific therapy area, e.g. tension-free vaginal tape. The main guidance of the Department of Health (London, UK) and associated bodies was also used.
压力性尿失禁是最常见的尿失禁形式。尽管它对生活质量有重大负面影响，但在英国，只有不到三分之一的患者会向其全科医生诉说症状。目前的主要治疗方法是盆底肌锻炼。以前，对于保守治疗无效的患者，唯一的选择就是手术干预。然而，最近的进展带来了第一种被证明对治疗压力性尿失禁有效的选择性5-羟色胺和去甲肾上腺素再摄取抑制剂。本文概述了当前的治疗方法以及一种口服药物在压力性尿失禁治疗中的地位。这篇综述文章包括通过PubMed检索到的使用搜索词“压力性尿失禁”、“治疗”以及特定治疗领域（如无张力阴道吊带）的论文。还采用了英国卫生部（伦敦）及相关机构的主要指导意见。
